Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,137 | -1,887 | -13,037 | -11,033 | -8,896 |
| Depreciation Amortization | 2 | 1 | 2,108 | 2,107 | 2,106 |
| Accounts payable and accrued liabilities | -400 | -744 | 2,159 | 4,860 | 4,179 |
| Other Working Capital | -153 | -366 | 1,680 | 5,087 | 4,556 |
| Other Operating Activity | 344 | 793 | -1,900 | -4,451 | -4,064 |
| Operating Cash Flow | $-4,344 | $-2,203 | $-8,990 | $-3,430 | $-2,119 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -8 | -8 | -8 |
| Investing Cash Flow | $N/A | $N/A | $-8 | $-8 | $-8 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 1,250 | 1,250 | 1,250 |
| Common Stock Issued | 10,460 | 5,500 | 12,262 | 12,250 | 12,262 |
| Common Stock Repurchased | N/A | N/A | N/A | 12 | N/A |
| Other Financing Activity | -1,571 | -1,014 | -2,715 | -6,595 | -6,595 |
| Financing Cash Flow | $8,889 | $4,486 | $10,797 | $6,917 | $6,917 |
| Beginning Cash Position | 1,808 | 1,808 | 9 | 9 | 9 |
| End Cash Position | 6,353 | 4,091 | 1,808 | 3,488 | 4,799 |
| Net Cash Flow | $4,545 | $2,283 | $1,799 | $3,479 | $4,790 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,344 | -2,203 | -8,990 | -3,430 | -2,119 |
| Capital Expenditure | N/A | N/A | -8 | -8 | -8 |
| Free Cash Flow | -4,344 | -2,203 | -8,998 | -3,438 | -2,127 |